Cort talks about hot topics in fibromyalgia research, future treatment possibilities, diagnosis, the difference between chronic fatigue syndrome and FM and more to the Sheffield ME and Fibromyalgia Association in the UK.
Nucynta, an opioid drug, was effective in reducing pain in fibromyalgia patients without small fiber neuropathy but was not effective in do so in FM patients with SFN.
High rates of alterations in the genes that produce mucosal proteins suggest that a damaged mucous layer in the eyes, nose or upper respiratory systems of people with chronic fatigue syndrome could be providing pathogens or toxins easier entry - possibly producing neuroinflammation and central sensitization.
Chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM) produce so many symptoms that diagnosing them can be difficult for uninformed doctors. While we know that small fiber polyneuropathy (SFPN) (or small fiber neuropathy (SFN) commonly occurs in both these diseases,...
Some studies a field waits for – and this is one. The past nerve fiber studies in fibromyalgia (FM) have tended to be small and use different methods and criteria – making it difficult to be clear about the extent of the problem. When a field gets to a...
The damage to the small nerve fibers in the skin and eyes of people with fibromyalgia has long been assumed to be caused some process in the body. Recent studies, though, suggest that, surprisingly enough, the brain could be trying to protect itself by eliminating nerve fibers in the body.
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.